Technological advances define shifting pathway signaling from normal to primary and metastatic colorectal cancer

Adoption of organoid/tumoroid propagation of normal and malignant intestinal epithelia has provided unparalleled opportunities to compare cell growth factor and signaling dependencies. These 3D structures recapitulate tumours in terms of gene expression regarding the tumor cells but also allow deeper insights into the contribution of the tumour microenvironment (TME). Elements of the TME can be manipulated or added back in the form of infiltrating cytotoxic lymphocytes and/or cancer associated fibroblasts. The effectiveness of chemo-, radio- and immunotherapies can be explored within weeks of deriving these patient-derived tumour avatars informing treatment of these exact patients in a timely manner. Entrenched paths to colorectal cancer (CRC) from the earliest steps of conventional adenoma or serrated lesion formation, and the recognition of further sub-categorisations embodied by consensus-molecular-subtypes (CMS), provide genetic maps allowing a molecular form of pathologic taxonomy. Recent advances in organoid propagation and scRNAseq are reshaping our understanding of CMS and CRC.

[1]  W. Wu,et al.  Cancer‐associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2–IGF1R and Hippo–YAP1 signaling pathways , 2022, The Journal of pathology.

[2]  C. Conrad,et al.  Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system , 2022, Journal of Experimental & Clinical Cancer Research.

[3]  Joshua D. Greenlee,et al.  A syngeneic MC38 orthotopic mouse model of colorectal cancer metastasis , 2022, Biology methods & protocols.

[4]  S. Prabhakar,et al.  Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer , 2022, Nature Genetics.

[5]  Seung Ah Lee,et al.  Modeling Pancreatic Cancer with Patient-Derived Organoids Integrating Cancer-Associated Fibroblasts , 2022, Cancers.

[6]  T. Benoukraf,et al.  Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironment. , 2022, Biomaterials.

[7]  B. Mroczko,et al.  Relationship between VEGF Family Members, Their Receptors and Cell Death in the Neoplastic Transformation of Colorectal Cancer , 2022, International journal of molecular sciences.

[8]  F. Hollande,et al.  Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models , 2022, Cancers.

[9]  Paige N. Vega,et al.  Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps , 2021, Cell.

[10]  F. Lordick,et al.  Primary and metastatic peritoneal surface malignancies , 2021, Nature Reviews Disease Primers.

[11]  M. Michael,et al.  Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer: A Systematic Review , 2021, Annals of Surgical Oncology.

[12]  Zhonghang Xu,et al.  TGF-beta signaling in cancer radiotherapy. , 2021, Cytokine.

[13]  Chin Wee Tan,et al.  Low-viscosity matrix suspension culture enables scalable analysis of patient-derived organoids and tumoroids from the large intestine , 2021, Communications Biology.

[14]  M. Hahne,et al.  The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis , 2021, Cancers.

[15]  J. Hogenesch,et al.  The Circadian Clock Gene, Bmal1, Regulates Intestinal Stem Cell Signaling and Represses Tumor Initiation , 2021, Cellular and molecular gastroenterology and hepatology.

[16]  R. Ramsay,et al.  Shifting the treatment paradigm for patients with deficient mismatch repair colon cancer: is there a role for immunotherapy? , 2021, ANZ journal of surgery.

[17]  J. Subramanian,et al.  Refining colorectal cancer classification and clinical stratification through a single-cell atlas , 2021, bioRxiv.

[18]  T. Seidle,et al.  Patient-Derived Xenograft vs. Organoids: A Preliminary Analysis of Cancer Research Output, Funding and Human Health Impact in 2014–2019 , 2020, Animals : an open access journal from MDPI.

[19]  Jie Cao,et al.  Mutations in the notch signalling pathway are associated with enhanced anti‐tumour immunity in colorectal cancer , 2020, Journal of cellular and molecular medicine.

[20]  F. Greten,et al.  AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancer , 2020, The Journal of experimental medicine.

[21]  A. Bennaceur-Griscelli,et al.  Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice , 2020, Nature Communications.

[22]  Andrew E. Rosselot,et al.  Ontogeny and function of the circadian clock in intestinal organoids , 2020, bioRxiv.

[23]  O. De Wever,et al.  Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases. , 2020, Trends in cancer.

[24]  J. Bienkowska,et al.  Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors , 2020, BMC Genomics.

[25]  T. Schumacher,et al.  Tumor organoid–T-cell coculture systems , 2019, Nature Protocols.

[26]  Qin Li,et al.  Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by VEGF-Mediated EZH2/VASH1 Pathway , 2019, Technology in cancer research & treatment.

[27]  W. Roth,et al.  Ex vivo tissue slice culture system to measure drug-response rates of hepatic metastatic colorectal cancer , 2019, BMC Cancer.

[28]  W. Scheithauer,et al.  Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  E. Cuppen,et al.  Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients , 2019, Science Translational Medicine.

[30]  Jessica A Lavery,et al.  A rectal cancer organoid platform to study individual responses to chemoradiation , 2019, Nature Medicine.

[31]  Satchidananda Panda,et al.  Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment. , 2019, Trends in cancer.

[32]  G. Fontanini,et al.  Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[33]  R. Steuer,et al.  The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer , 2018, EBioMedicine.

[34]  Pornpimol Charoentong,et al.  Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution , 2018, Nature Communications.

[35]  I. B. Borel Rinkes,et al.  Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases , 2018, The British journal of surgery.

[36]  E. Voest,et al.  Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery. , 2017, Cell chemical biology.

[37]  J. Pignon,et al.  Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials † , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[38]  Toshiro Sato,et al.  Defining the role of Lgr5+ stem cells in colorectal cancer: from basic research to clinical applications , 2017, Genome Medicine.

[39]  R. Lothe,et al.  Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies , 2017, Molecular Cancer.

[40]  I. B. Borel Rinkes,et al.  Neoadjuvant chemotherapy affects molecular classification of colorectal tumors , 2017, Oncogenesis.

[41]  S. Kopetz,et al.  Recent developments in the treatment of metastatic colorectal cancer , 2017, Therapeutic advances in medical oncology.

[42]  R. Nusse,et al.  Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities , 2017, Cell.

[43]  B. Leggett,et al.  Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis , 2017, Gut.

[44]  L. J. K. Wee,et al.  Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors , 2017, Nature Genetics.

[45]  W. Frankel,et al.  Molecular genetics of microsatellite-unstable colorectal cancer for pathologists , 2017, Diagnostic Pathology.

[46]  Y. Tomita,et al.  p53 functional deficiency in human colon cancer cells promotes fibroblast-mediated angiogenesis and tumor growth. , 2016, Carcinogenesis.

[47]  Cord Langner,et al.  MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance , 2016, Virchows Archiv.

[48]  Toshio Uraoka,et al.  A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis. , 2016, Cell stem cell.

[49]  M. Katoh.  FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review) , 2016, International journal of molecular medicine.

[50]  Jeffrey S. Morris,et al.  The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.

[51]  J. Malaterre,et al.  Intestinal-specific activatable Myb initiates colon tumorigenesis in mice , 2015, Oncogene.

[52]  Hans Clevers,et al.  SnapShot: Growing Organoids from Stem Cells , 2015, Cell.

[53]  N. Nagarajan,et al.  Cloning and Variation of Ground State Intestinal Stem Cells , 2015, Nature.

[54]  Hayley E. Francies,et al.  Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients , 2015, Cell.

[55]  Hans Clevers,et al.  Sequential cancer mutations in cultured human intestinal stem cells , 2015, Nature.

[56]  J. Malaterre,et al.  Peritoneal Tumorigenesis and Inflammation are Ameliorated by Humidified-Warm Carbon Dioxide Insufflation in the Mouse , 2015, Annals of Surgical Oncology.

[57]  R. Tothill,et al.  Cohesin Rad21 mediates loss of heterozygosity and is upregulated via Wnt promoting transcriptional dysregulation in gastrointestinal tumors. , 2014, Cell reports.

[58]  J. Malaterre,et al.  Tripartite interactions between Wnt signaling, Notch and Myb for stem/progenitor cell functions during intestinal tumorigenesis. , 2014, Stem cell research.

[59]  J. Castle,et al.  Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma , 2014, BMC Genomics.

[60]  Jens T Siveke,et al.  EGF receptor is required for KRAS-induced pancreatic tumorigenesis. , 2012, Cancer cell.

[61]  J. Malaterre,et al.  Myb Controls Intestinal Stem Cell Genes and Self‐Renewal , 2011, Stem cells.

[62]  Hans Clevers,et al.  Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. , 2011, Gastroenterology.

[63]  Hans Clevers,et al.  Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts , 2011, Nature.

[64]  S. Artavanis-Tsakonas,et al.  Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine , 2009, Proceedings of the National Academy of Sciences.

[65]  P. Darcy,et al.  Frizzled-7 dictates three-dimensional organization of colorectal cancer cell carcinoids , 2007, Oncogene.

[66]  H. Clevers,et al.  c-Myb is required for progenitor cell homeostasis in colonic crypts , 2007, Proceedings of the National Academy of Sciences.

[67]  Takeshi Oshima,et al.  Mitogenic Influence of Human R-Spondin1 on the Intestinal Epithelium , 2005, Science.

[68]  Andrew P. Weng,et al.  Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.

[69]  B. Iacopetta.  Are there two sides to colorectal cancer? , 2002, International journal of cancer.

[70]  A. Dignass,et al.  Peptide growth factors in the intestine. , 2001, European journal of gastroenterology & hepatology.

[71]  R. Ramsay,et al.  c-Myb is critical for murine colon development , 1999, Oncogene.

[72]  Hans Clevers,et al.  Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models , 2017, Cell Death & Differentiation.